Zhencong W. Chen

180 Fenglin Road
Xuhui, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

The stem cell atlas of lung adenocarcinoma: A stemness blueprint for prognosis and immunotherapy success.

The stem cell atlas of lung adenocarcinoma: A stemness blueprint for prognosis and immunotherapy success.

Journal: Translational oncology

Published: October 17, 2025

Targeting UXS1-Dependent Glucuronate Detoxification Potentiates Metformin's Anti-Tumor Efficacy in Lung Adenocarcinoma.

Targeting UXS1-Dependent Glucuronate Detoxification Potentiates Metformin's Anti-Tumor Efficacy in Lung Adenocarcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 08, 2025

CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancer.

CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancer.

Journal: Cancer communications (London, England)

Published: March 14, 2025

HER2 mutations in pulmonary adenocarcinoma presenting with ground-glass nodules.

HER2 mutations in pulmonary adenocarcinoma presenting with ground-glass nodules.

Journal: World journal of surgical oncology

Published: March 13, 2025

Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma.

Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma.

Journal: Cell discovery

Published: December 31, 2024

Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing.

Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing.

Journal: eLife

Published: December 27, 2024

Analysis of the Clinicopathological Characteristics, Genetic Phenotypes, and Prognostics of Primary Pulmonary and Bronchial Adenoid Cystic Carcinoma.

Analysis of the Clinicopathological Characteristics, Genetic Phenotypes, and Prognostics of Primary Pulmonary and Bronchial Adenoid Cystic Carcinoma.

Journal: Thoracic cancer

Published: August 28, 2024

Dissection of the cell communication interactions in lung adenocarcinoma identified a prognostic model with immunotherapy efficacy assessment and a potential therapeutic candidate gene ITGB1.

Dissection of the cell communication interactions in lung adenocarcinoma identified a prognostic model with immunotherapy efficacy assessment and a potential therapeutic candidate gene ITGB1.

Journal: Heliyon

Published: May 24, 2024

The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors.

The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors.

Journal: Pharmaceutical research

Published: April 16, 2024

IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.

IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 29, 2023

Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma.

Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma.

Journal: Cell reports

Published: September 18, 2023

Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma.

Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma.

Journal: Cancer letters

Published: August 22, 2023

Showing 1-12 of 64

Last Updated: 09/26/2026